Literature DB >> 21617913

HIF-1 is involved in high glucose-induced paracellular permeability of brain endothelial cells.

Jingqi Yan1, Ziyan Zhang, Honglian Shi.   

Abstract

Experimental evidence from human patients and animal models of diabetes has demonstrated that hyperglycemia increases blood-brain barrier (BBB) permeability, which is associated with increased risk of neurological dysfunction. However, the mechanism underlying high glucose-induced BBB disruption is not understood. Here we investigated the role of hypoxia-inducible factor-1 (HIF-1) in high glucose-induced endothelial permeability in vitro using mouse brain microvascular endothelial cells (b.End3). Our results demonstrated that high glucose (30 mM) upregulated the protein level of HIF-1α, the regulatable subunit of HIF-1, and increased the transcriptional activity of HIF-1 in the endothelial cells. At the same time, high glucose increased the paracellular permeability associated with diminished expression and disrupted continuity of tight junction proteins occludin and zona occludens protein-1 (ZO-1) of the endothelial cells. Upregulating HIF-1 activity by cobalt chloride increased the paracellular permeability of the endothelial cells exposed to normal glucose (5.5 mM). In contrast, downregulating HIF-1 activity by HIF-1α inhibitors and HIF-1α specific siRNA ameliorated the increased paracellular permeability and the alterations of distribution pattern of occludin and ZO-1 induced by high glucose. In addition, high glucose increased expression of vascular endothelial growth factor (VEGF), a downstream gene of HIF-1. Inhibiting VEGF improved the expression pattern of occludin and ZO-1, and attenuated the endothelial leakage. Furthermore, key results were confirmed in human brain microvascular endothelial cells. These results strongly indicate that HIF-1 plays an important role in high glucose-induced BBB dysfunction. The results will help us understand the molecular mechanisms involved in hyperglycemia-induced BBB dysfunction and neurological outcomes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21617913     DOI: 10.1007/s00018-011-0731-5

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  66 in total

1.  Diabetes underlies common neurological disorders.

Authors:  Anders A F Sima
Journal:  Ann Neurol       Date:  2004-10       Impact factor: 10.422

2.  Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF.

Authors:  Vassiliki Poulaki; Wenying Qin; Antonia M Joussen; Peter Hurlbut; Stanley J Wiegand; John Rudge; George D Yancopoulos; Anthony P Adamis
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

3.  Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO.

Authors:  S Fischer; M Clauss; M Wiesnet; D Renz; W Schaper; G F Karliczek
Journal:  Am J Physiol       Date:  1999-04

4.  Regulation of vascular endothelial growth factor expression by advanced glycation end products.

Authors:  C Treins; S Giorgetti-Peraldi; J Murdaca; E Van Obberghen
Journal:  J Biol Chem       Date:  2001-09-24       Impact factor: 5.157

5.  PGC-1alpha is coupled to HIF-1alpha-dependent gene expression by increasing mitochondrial oxygen consumption in skeletal muscle cells.

Authors:  Kathleen A O'Hagan; Sinead Cocchiglia; Alexander V Zhdanov; Murtaza M Tambuwala; Murtaza M Tambawala; Eoin P Cummins; Mona Monfared; Terence A Agbor; John F Garvey; Dmitri B Papkovsky; Cormac T Taylor; Bernard B Allan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-28       Impact factor: 11.205

6.  2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF.

Authors:  Nicola J Mabjeesh; Daniel Escuin; Theresa M LaVallee; Victor S Pribluda; Glenn M Swartz; Michelle S Johnson; Margaret T Willard; Hua Zhong; Jonathan W Simons; Paraskevi Giannakakou
Journal:  Cancer Cell       Date:  2003-04       Impact factor: 31.743

Review 7.  Diabetes, vascular complications and antiplatelet therapy: open problems.

Authors:  A M Cerbone; N Macarone-Palmieri; G Saldalamacchia; A Coppola; G Di Minno; A A Rivellese
Journal:  Acta Diabetol       Date:  2008-12-02       Impact factor: 4.280

Review 8.  Mitochondrial complex III regulates hypoxic activation of HIF.

Authors:  T Klimova; N S Chandel
Journal:  Cell Death Differ       Date:  2008-01-25       Impact factor: 15.828

Review 9.  Neurodegenerative disorders associated with diabetes mellitus.

Authors:  Michael Ristow
Journal:  J Mol Med (Berl)       Date:  2004-06-03       Impact factor: 4.599

10.  Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate.

Authors:  A P Adamis; D T Shima; M J Tolentino; E S Gragoudas; N Ferrara; J Folkman; P A D'Amore; J W Miller
Journal:  Arch Ophthalmol       Date:  1996-01
View more
  39 in total

Review 1.  Factors controlling permeability of the blood-brain barrier.

Authors:  Mohammed M A Almutairi; Chen Gong; Yuexian G Xu; Yanzhong Chang; Honglian Shi
Journal:  Cell Mol Life Sci       Date:  2015-09-24       Impact factor: 9.261

2.  High glucose enhances HIV entry into T cells through upregulation of CXCR4.

Authors:  Xiqian Lan; Kang Cheng; Nirupama Chandel; Rivka Lederman; Aakash Jhaveri; Mohammad Husain; Ashwani Malhotra; Pravin C Singhal
Journal:  J Leukoc Biol       Date:  2013-08-02       Impact factor: 4.962

3.  Diabetes Mellitus and Blood-Brain Barrier Dysfunction: An Overview.

Authors:  Shikha Prasad; Ravi K Sajja; Pooja Naik; Luca Cucullo
Journal:  J Pharmacovigil       Date:  2014-06

Review 4.  Ascorbic acid repletion: A possible therapy for diabetic macular edema?

Authors:  James M May
Journal:  Free Radic Biol Med       Date:  2016-02-17       Impact factor: 7.376

5.  Glucagon-Like Peptide-1 Strengthens the Barrier Integrity in Primary Cultures of Rat Brain Endothelial Cells Under Basal and Hyperglycemia Conditions.

Authors:  Shuji Fukuda; Shinsuke Nakagawa; Rie Tatsumi; Yoichi Morofuji; Tomonori Takeshita; Kentaro Hayashi; Kunihiko Tanaka; Takayuki Matsuo; Masami Niwa
Journal:  J Mol Neurosci       Date:  2015-12-11       Impact factor: 3.444

6.  Vascular tight junction disruption and angiogenesis in spontaneously hypertensive rat with neuroinflammatory white matter injury.

Authors:  Yi Yang; Shihoko Kimura-Ohba; Jeffrey F Thompson; Victor M Salayandia; Melissa Cossé; Limor Raz; Fakhreya Y Jalal; Gary A Rosenberg
Journal:  Neurobiol Dis       Date:  2018-02-24       Impact factor: 5.996

7.  Role of Hypoxia Inducible Factor 1 in Hyperglycemia-Exacerbated Blood-Brain Barrier Disruption in Ischemic Stroke.

Authors:  Ziyan Zhang; Jingqi Yan; Honglian Shi
Journal:  Neurobiol Dis       Date:  2016-07-16       Impact factor: 5.996

8.  Pyrroloquinoline quinone protects mouse brain endothelial cells from high glucose-induced damage in vitro.

Authors:  Zhong Wang; Guo-qiang Chen; Gui-ping Yu; Chang-jian Liu
Journal:  Acta Pharmacol Sin       Date:  2014-10-06       Impact factor: 6.150

Review 9.  Blood-brain barrier dysfunction and recovery after ischemic stroke.

Authors:  Xiaoyan Jiang; Anuska V Andjelkovic; Ling Zhu; Tuo Yang; Michael V L Bennett; Jun Chen; Richard F Keep; Yejie Shi
Journal:  Prog Neurobiol       Date:  2017-10-05       Impact factor: 11.685

10.  Increased susceptibility to amyloid-β toxicity in rat brain microvascular endothelial cells under hyperglycemic conditions.

Authors:  Cristina Carvalho; Paige S Katz; Somhrita Dutta; Prasad V G Katakam; Paula I Moreira; David W Busija
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.